Literature DB >> 5001001

Passive immunotherapy of leukemia and other cancer.

R Motta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5001001     DOI: 10.1016/s0065-230x(08)60520-5

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  8 in total

1.  Experimental model of serum therapy for metastasized rabbit transplantable tumors (inhibition of metastatic lesions and life-prolongation).

Authors:  K Nakano; H Tokita; H Amemiya; S Suzuki; K Ohmori; Y Kimura; N Tanaka; T Ueno
Journal:  Jpn J Surg       Date:  1980-06

2.  Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumours.

Authors:  G Mathé
Journal:  Drugs       Date:  1974       Impact factor: 9.546

3.  Immunotherapy of human leukemia with antibody to pluripotential K-562 stem cells.

Authors:  J Izquierdo; E R Robbio; B B Lozzio; W Hanna
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

4.  Antibody-mediated suppression of grafted lymphoma. IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibody.

Authors:  H S Shin; J S Economou; G R Pasternack; R J Johnson; M L Hayden
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

5.  Antibody-induced changes in levels of cyclic adenosine monophosphate in leukaemic lymphocytes.

Authors:  M Virji; G T Stevenson
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

6.  The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.

Authors:  A J Rowland; M E Harper; D W Wilson; K Griffiths
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

7.  Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.

Authors:  M F Woodruff; M P Inchley; N Dunbar
Journal:  Br J Cancer       Date:  1972-04       Impact factor: 7.640

8.  Characterization of a monoclonal antibody to L1210 leukaemia.

Authors:  C Testorelli; S Morelli; A Goldin; A Nicolin
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.